MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen EPS Ratio 2011-2026 | INGN
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.86 | -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.96 | 2.44 | 1.02 | 1.02 | 0.6 | 0.33 | 0.76 | -20 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.44 | -20 | -1.7 |
Quarterly EPS Ratio Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.2 | -0.15 | -0.25 | - | -0.25 | -0.24 | -0.62 | - | -1.97 | -0.42 | -0.88 | - | -0.42 | -0.15 | -0.62 | - | 0.54 | 0.23 | -0.03 | -0.23 | -0.08 | 0.12 | -0.07 | -0.06 | 0.31 | 0.47 | 0.24 | 0.47 | 0.77 | 0.69 | 0.51 | -0.03 | 0.35 | 0.4 | 0.29 | 0.26 | 0.26 | 0.38 | 0.13 | 0.2 | 0.14 | 0.18 | 0.08 | 0.08 | 0.12 | 0.13 | -0.01 | 0.91 | -3.9 | -2.98 | -3.65 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.91 | -3.9 | -0.19 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B |  USA |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.09 | $ 9.38 | -1.78 % | $ 722 M | USA |
 |
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
Stryker Corporation
SYK
|
2.21 | $ 332.68 | 1.57 % | $ 127 B | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 9.13 | -0.76 % | $ 327 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Tandem Diabetes Care
TNDM
|
-0.01 | $ 23.32 | -3.87 % | $ 1.59 B | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
Outset Medical
OM
|
-5.37 | $ 3.52 | -0.28 % | $ 53.5 K | USA |
 |
PAVmed
PAVM
|
-9.16 | $ 8.94 | -3.87 % | $ 64.7 M | USA |
 |
CONMED Corporation
CNMD
|
1.52 | $ 36.64 | -1.19 % | $ 1.14 B | USA |
 |
Electromed
ELMD
|
0.89 | $ 24.45 | -0.85 % | $ 207 M | USA |
 |
Viemed Healthcare
VMD
|
0.38 | $ 9.22 | -1.39 % | $ 359 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.38 | $ 0.6 | -10.61 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
-8.58 | $ 2.27 | -2.16 % | $ 3.54 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
-4.45 | $ 63.65 | 0.55 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
-0.76 | $ 1.73 | -2.26 % | $ 111 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 11.41 | 0.18 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
4.57 | $ 336.42 | 0.04 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
0.33 | $ 3.94 | -3.9 % | $ 582 M | USA |
 |
TELA Bio
TELA
|
-0.83 | $ 0.75 | 8.11 % | $ 35.2 M | USA |
 |
Invacare Corporation
IVC
|
-0.54 | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
-0.37 | $ 0.68 | -2.2 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
-13.7 | - | - | $ 1.08 M | USA |
 |
Beyond Air
XAIR
|
-0.69 | $ 0.69 | -6.74 % | $ 46.7 M | USA |
 |
Inspire Medical Systems
INSP
|
4.95 | $ 50.45 | -1.87 % | $ 1.48 B | USA |
 |
Xtant Medical Holdings
XTNT
|
-0.12 | $ 0.57 | 0.53 % | $ 76.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
-1.33 | $ 1.24 | -4.62 % | $ 50.5 M | USA |
 |
Varex Imaging Corporation
VREX
|
-1.7 | $ 10.78 | 0.84 % | $ 446 M | USA |
 |
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | USA |